China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 23.24 CNY 0.26% Market Closed
Market Cap: 11.7B CNY

Intrinsic Value

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 32.28 CNY. Compared to the current market price of 23.24 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 28%.

Intrinsic Value
32.28 CNY
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
China Resources Boya Bio pharmaceutical Group Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about China Resources Boya Bio pharmaceutical Group Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is China Resources Boya Bio pharmaceutical Group Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for China Resources Boya Bio pharmaceutical Group Co Ltd.

Explain Valuation
Compare China Resources Boya Bio pharmaceutical Group Co Ltd to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
China Resources Boya Bio pharmaceutical Group Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about China Resources Boya Bio pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
China Resources Boya Bio pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall St
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
28.28 CNY
22% Upside
Average
Price Target
31.78 CNY
37% Upside
Highest
Price Target
36.75 CNY
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Resources Boya Bio pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock?

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 32.28 CNY.

Is China Resources Boya Bio pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 23.24 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 28%.

Back to Top